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Abstract

Analysis

Background: The goal of our study was to determine the impact
of gastrointestinal bleeding (GIB) on in-hospital outcomes among
acute respiratory distress syndrome (ARDS) patients, and subsequently determine the potential risk factors for the development of
GIB.
Methods: ARDS patients with and without GIB were identified using
the National Inpatient Sample (2002 - 2012). Linear regression analysis was used to assess impact of GIB on in-hospital mortality, length
of stay and total charges. Univariate logistic regression was used to
determine associated odds ratios (OR) for causes of ARDS and common comorbid conditions.
Results: We identified 149,190 ARDS patients. The incidence of GIB
was the highest among patients > 60 years (P < 0.001). GIB was associated with longer hospitalization days (7.3 days versus 11.9 days,
P < 0.001), higher mortality (11% versus 27%, P < 0.001) and greater
economic burden ($82,812 versus $45,951, P < 0.001). GIB was common in cirrhosis (OR: 8.3), peptic ulcer disease (OR: 3.7), coagulopathy disorders (OR: 3.003), thrombocytopenia (OR: 2.6), anemia (OR:
2.5) and atrial fibrillation (OR: 1.5). ARDS secondary to aspiration
pneumonia (OR: 2.0), pancreatitis (OR: 2.0), sepsis (OR: 1.6) and
community acquired pneumonia (OR: 0.8) was more likely to have
GIB.
Conclusion: Our study demonstrates that GIB in ARDS patients is
associated with significant increased mortality, hospitalization and
health care cost.
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Introduction
Acute respiratory distress syndrome (ARDS) is a complex
disorder characterized by diffuse capillary endothelial and alveolar damage. Early reports in 1978 described an increased
incidence of gastrointestinal bleeding (GIB) at a rate of 11 out
of 13 ARDS patients compared to 4 out of 44 mechanically
ventilated chronic obstructive pulmonary disease (COPD) patients [1].
Overt GIB is a known complication ranging between
1.5% and 8.5% in critically ill patients [2-4]. In this setting,
prolonged mechanical ventilation for >48 h and coagulopathy
are well-described risk factors for gastrointestinal bleeding
[5]. ARDS appears to be an additional condition that sets the
stage for developing a specific gut injury leading to bleeding.
The underlying stress-related mucosal damage (SRMD) in
this setting could range from asymptomatic superficial lesions
and occult GIB to deeper mucosal injury and overt clinically
significant hemorrhage [6]. The pathophysiology of SRMD is
explained by disruption of the gastric mucosal barrier due to
reduced gastric blood flow, increased reflux of bile salts and
uremic toxins along with reperfusion injury [1, 7]. SRMD is
responsible for the majority of GIB in mechanically ventilated
patients. It has been postulated that 75-100% of critically ill
patients will have endoscopically detected stress-related mucosal erosions and subepithelial hemorrhages within 24 h of
their admission to the critical care unit [8-10].
The current standards in the management of ARDS follows a lung-protective strategy using low tidal volumes (TVs)
and increased positive end-expiratory pressures (PEEP) to
prevent atelectasis and support oxygenation. This increased
PEEP results in decreased venous return and cardiac output,
which leads to splanchnic hypoperfusion and ischemic injury
to the gastric mucosa. This condition is also associated with
increased plasma-renin-angiotensin-aldosterone activity and
elevated catecholamines, which results in vasoconstriction and
further compromise to the gastric blood flow [11-14].
To our knowledge, this is the first large-scale national database analysis that looked at the incidence and predictors of
GIB among hospitalized patients with ARDS.
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We conducted a study utilizing the National Inpatient
Sample (NIS) database with the primary aim to determine the
incidence of gastrointestinal hemorrhage among patients admitted with ARDS. As a secondary aim, we intended to analyze the comorbidities contributing to increased risk of GIB
in those patients, and to evaluate the length of hospital stay,
attributed health cost burden and mortality rates among ARDS
patients with GIB versus those who did not develop GIB.

tals, and/or had a full-time equivalent interns and residents to
provide a patient ratio of 0.25 were considered as “teaching
hospitals”. The cost of each hospitalization was calculated
by merging the data with cost to charge ratio from the HCUP
database. This was standardized and adjusted for each year.
The cost of each year was adjusted in reference to the 2016
US dollar value by using the consumer price index to account
for inflation.

Patients and Methods

Outcomes

Data source

Our objectives were as follows: 1) the primary objective was
to analyze the incidence of GIB in patients hospitalized with
ARDS in a cohort group of individuals admitted between 2002
and 2012; 2) the secondary objective was to investigate the
independent predictors of GIB in patients with ARDS. We
analyzed the following well-established comorbidities associated with GIB: alcoholism, past or current peptic ulcer disease (PUD), underlying liver disease, atrial fibrillation (AF),
congestive heart failure (CHF), valvular heart disease, renal
failure, anemia, past history of GIB, coagulation disorders,
and gastrointestinal malignancies including esophageal, gastric, small intestinal, colorectal cancers [18]. Established risk
factors for the development of ARDS like sepsis and septic
shock, aspiration pneumonia and community-acquired pneumonia, burns and pancreatitis were also studied [19]. We also
compared the LOS and cost per hospitalization of patients with
ARDS and GIB versus those who did not have GIB. Mortality
rates between the two groups were also assessed.

A retrospective longitudinal analysis of all adult patients (>
18 years) admitted in the USA from 2002 to 2012 with the
diagnosis of ARDS was performed using the NIS database.
The NIS database was developed by the Health Care Cost and
Utilization Project (HCUP) and is the largest publicly available all-payer inpatient care database available in the USA.
This database is known for its utility in studying trends and
outcomes of various diseases and procedures [15-17], and it
comprises stratified data collected from 20% of US community hospitals, in the form of de-identified information on individual hospitalizations that includes demographics, insurance
status, comorbidities, admission status, discharge diagnoses,
procedures, outcomes, length of stay (LOS) and cost of hospitalization.
Study population
Using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, we identified
all hospitalizations among adults > 18 years of age, admitted
with a primary or secondary diagnosis of ARDS, from 2002
through 2012. Hospitalizations with missing age, gender, admission and discharge diagnoses or mortality were excluded.
We also collected variable etiologies of ARDS to include community-acquired pneumonia, aspiration pneumonia, sepsis or
septic shock, pancreatitis and burns.
Definition of variables
The NIS variables were utilized to identify patients’ age, gender and race. Age was divided into five categories: younger
than 20 years, 20 - 39 years, 40 - 59 years, 60 - 79 years
and older than 80 years. Race was divided into white, black,
Hispanic, Asian or Pacific Islander, and Native American. A
modified Charlson comorbidity index (CCI) was used to define the severity of the associated comorbid conditions. The
scores ranged from 0 to 33 with higher scores corresponding to a greater burden of comorbid disease and vice versa.
Hospital bed size and its location as urban or rural were also
taken into account. Hospitals that upheld an Accreditation
Council for Graduate Medical Education-accredited residency program, a membership of the Council of Teaching Hospi-

Statistical analysis
ARDS patients were captured by ICD-9 code 518.82 whether
ARDS was a primary or a secondary diagnosis. GIB in those
patients was also extracted using the corresponding clinical
classification software codes. A Chi-square test or analysis
of variance (ANOVA) was accordingly used to identify the
demographical differences between ARDS patients with and
without GIB. A two-sample t-test was used to assess for impact of GIB on in-hospital mortality, LOS and total charges
for ARDS patients with or without GIB. A univariate logistic
regression analysis was used to calculate odds ratios (OR) for
causes of ARDS, comorbid conditions and their associations
with the incidence of GIB. A Multivariate analysis of significant co-morbidities was then performed to account for any
confounders among the significant comorbidities.

Results
A total of 149,190 patients (older than 18 years) were identified between 2002 and 2012 with a discharge diagnosis of
ARDS. A total of 3,988 of those patients with ARDS developed GIB. The mortality rate during hospitalization was significantly higher in patients with ARDS complicated by GIB
reaching to 27% when compared to 11% in patients without
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Table 1. Baseline Characteristics and Demographics of ARDS Patients With and Without GIB
GIB during hospitalization
Demographics

No

Yes

P value

No.

%

No.

%

Total

145,202

97.33

3,988

2.67

Age group (years)

29,466

99.49

151

0.51

   20 - 39

11,863

98.26

210

1.74

   40 - 59

28,252

97.08

850

2.92

   60 - 79

43,518

96.49

1,581

3.51

   ≥ 80

31,917

96.4

1,193

3.6

Age, mean (SD)

53.38 (0.09)

Race

75,133

97.18

2,184

2.82

  Black

18,245

97.65

440

2.35

  Hispanic

14,666

97.96

305

2.04

   Asian or Pacific Islander

2,633

96.31

101

3.69

  Native American

840

98.13

16

1.87

  Other

3,659

97.31

101

2.69

Gender

75,315

97.47

1,556

2.53

69,701

97.2

1,591

2.8

< 0.001

  < 20

66.58 (0.36)

< 0.001
< 0.001

  White

0.008

  Female
  Male
Insurance
  Medicare

70,326

96.51

2,544

3.49

  Medicaid

27,919

98.40

454

1.60

< 0.001

  Private insurance

35,970

98.11

693

1.89

  Self-pay

5,877

96.96

184

3.04

  No charge

640

98.01

13

1.99

  Other

4,068

97.86

89

2.14

  Rural

21,264

97.85

468

2.15

   Urban non-teaching

50,658

97.18

1471

2.82

   Urban teaching

72,878

97.28

2,038

2.72

Length of stay, mean (SD)

7.37 (0.03)

11.93 (0.24)

< 0.001

In-hospital mortality, mean (SD)

0.11 (0.00)

0.27 (0.01)

< 0.001

Total charges, mean (SD)

45,951.04 (227.42)

82,812.09 (2,226.03)

< 0.001

Hospital type

GIB (P < 0.001).
Table 1 shows the baseline characteristics and demographics of patients with ARDS with and without GIB. The mean
age of patients with ARDS who had GIB was 67 years, and
more than 7% of these individuals were over 60 years of age.
There was no significant gender difference among the patients
who had GIB. Asians and Pacific Islanders exhibited a significantly higher risk of GIB when compared to other races
(3.69%; P < 0.001). Patients who had GIB were more likely
to have Medicare as their medical coverage provider (3.49%;
44

< 0.001

P < 0.001). Most ARDS patients with GIB had CCI index >
2. Patients with ARDS who had GIB had significantly longer
length of hospital stay of 11.93 days (SD: 0.24; P < 0.001)
as compared to 7.37 days (SD: 0.03; P < 0.001) for patients
who did not develop a GIB. The mean hospital cost was also
inflated in patients with GIB as compared to patients without
GIB ($82,812 versus $45,951; P < 0.001).
Table 2 shows the various comorbidities that were associated with an increased risk of GIB. Patients with pre-existing
gastrointestinal conditions like cirrhosis and peptic ulcer dis-
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Table 2. Risk Factors Associated With GIB in Patients With ARDS (CCI: Charlson Comorbidity Index)
Comorbidity

Odds ratio

Gastroesophageal reflux disease

0.754

0.669

0.85

< 0.001

Atrial fibrillation

1.549

1.431

1.676

< 0.001

Cirrhosis

8.356

7.414

9.418

< 0.001

Peptic ulcer disease

3.705

3.079

4.458

< 0.001

Rheumatoid arthritis

0.789

0.571

1.09

0.1354

Valvular heart disease

1.08

0.967

1.205

0.1749

Coronary artery disease

1.063

0.982

1.151

0.1325

Hypertension

1.048

0.983

1.118

0.1547

Chronic obstructive pulmonary disorder

1.041

0.96

1.128

0.3415

Diabetes

0.982

0.909

1.06

0.6351

Tobacco use disorder

0.673

0.583

0.777

< 0.001

Pancytopenia

2.624

1.942

3.544

< 0.001

End-stage renal disease

0.876

0.695

1.104

0.2521

Congestive heart failure

1.388

1.298

1.484

< 0.001

Anemia

2.472

2.312

2.644

< 0.001

Peripheral vascular disease

1.304

1.114

1.525

0.0009

TIA/stroke

1.166

1.033

1.316

0.0126

Weekend admission

1.035

0.962

1.114

0.3617

Coagulopathy

3.003

2.738

3.294

< 0.001

Diverticular bleeding

2.742

1.441

5.218

< 0.001

Esophageal cancer

1.23

0.707

2.14

0.4628

Stomach cancer

3.09

2.035

4.692

< 0.001

Colon cancer

1.813

1.431

2.299

< 0.001

CCI index ≥ 2

2.478

2.294

2.677

< 0.001

ease had higher predisposition to develop GIB with an odds
ratio (OR) of 8.4 (95% CI: 7.4 - 9.4) and 3.7 (95% CI: 1.4
- 1.7), respectively. Patients with a history of gastric cancer, diverticular bleeding and colon cancer were more likely to have
GIB. However, patients with gastroesophageal reflux disease
(GERD) had a relatively lower OR (OR: 0.8; 95% CI: 0.7 0.9) of having a GIB. Furthermore, patients with coagulopathy
(OR: 3.003; P < 0.001), pancytopenia (OR: 2.6; P < 0.001)
and anemia (OR: 2.5; P < 0.001) had higher likelihood of developing GIB. Other conditions which raised the risk of GIB
included AF and CHF.
On the other hand, comorbidities like coronary artery
disease (CAD), valvular heart disease, hypertension, COPD,

95% confidence interval

P value

diabetes, end-stage renal disease (ESRD), rheumatoid arthritis
and tobacco use had a relatively lower incidence of GIB.
Table 3 shows the most common causes of ARDS and
their attributed increased risk of GIB. These included aspiration pneumonia, pancreatitis and sepsis in decreasing order.
ARDS secondary to burns had lower OR to have a GIB.

Discussion
Our study is the largest to date, where a nationwide analysis of
the incidence of GIB in individuals admitted to intensive care
units with ARDS, was performed. Data collected over a decade

Table 3. Common Etiologies of ARDS and Their Risk for GIB
Cause

Odds ratio

95% confidence interval

Aspiration pneumonia

2.098

1.916

2.296

< 0.001

Pancreatitis

2.016

1.633

2.49

< 0.001

Sepsis

1.622

1.439

1.828

< 0.001

Pneumonia

0.833

0.776

0.894

< 0.001

Burns

0.385

0.096

1.552

0.1797
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using the NIS database were evaluated. Our findings could be
summarized by the following: 1) there is an increased incidence of GIB among critically ill patients suffering ARDS particularly in elderly individuals; 2) the hospital mortality rate
among ARDS patients with GIB was significantly increased
compared to the control group who did not develop GIB; 3)
predictors of GIB included advanced age, cirrhosis and peptic
ulcer disease; 4) potential causes of ARDS that were statistically linked to an increased risk of GIB were aspiration pneumonia, pancreatitis and sepsis or septic shock; 5) in addition,
there was a significant increase in overall length of hospital
stay and attributed health care cost among patients whose
course of stay was complicated by GIB.
The incidence of GIB among ARDS patients in our study
reached around 2.67%. This is comparable to a multicenter
prospective trial by Krag et al, where the authors reported a
GIB rate of 2.6% (95% CI: 1.6-3.6%) among mechanically ventilated critically ill patients [3]. Similar results with a
prevalence ranging from 0.6% to 4% have been reported in
the literature as well [5, 20]. This is in contrast to the earlier
reports in 1978 where overt GIB rates were thought to be as
high as 25% in critically ill patients [21]. This difference could
be explained in part by an overall improvement in the management of critically ill patients, ranging from early aggressive
resuscitation, institution of early enteral nutrition, as well as
increasing use of prophylactic acid suppression measures to
prevent stress ulcer formation [22-24].
An acute or chronic underlying liver disease has been described in the literature by Barletta to be an independent risk
factor for GIB among patients with severe sepsis and septic
shock [25]. Our data comparably showed a significant increased risk of GIB among ARDS patients with liver cirrhosis
(OR: 8.36 (95% CI: 0.66 - 0.85); P < 0.0001) and a history of
peptic ulcer disease (OR: 3.705; P < 0.0001). Other potential
risk factors that we were able to identify in our ARDS study
group included coagulopathy, pancytopenia and anemia. Various studies in the past have demonstrated an independent correlation between GIB and coagulopathy or thrombocytopenia
in critically ill patients [3, 5, 26]. Approximately 95% of all
patients admitted to the intensive care unit are reported to exhibit a drop in their hemoglobin by their third day of stay [27].
Our study elucidated other comorbidities that were independently linked to a higher incidence of GIB like AF, CHF
and history of diverticular bleeding or gastrointestinal malignancies. An earlier retrospective study reported in 2003 by
Faisy et al analyzed the incidence of GIB in critically ill patients who received stress ulcer prophylaxis in comparison to
patients who did not. The patients who developed clinically
significant GIB were found to have a higher Simplified Acute
Physiology Score (SAPS II) [22]. Similarly, another study by
Krag et al demonstrated a higher Sequential Organ Failure Assessment (SOFA) score to be an independent risk factor for
GIB in sick patients admitted to the critical care unit [3]. These
studies further illustrate the attributed increased risk of GIB in
critically ill patients with ARDS and multiple other associated
comorbidities.
On another note, ARDS patients who receive positive
pressure ventilation (PPV) for >3 days are in particular susceptible to mucosal damage due to splanchnic hypo-perfusion
46
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that furthermore worsens when the PEEP levels up to 15 – 20
cm of H2O [28]. The surviving sepsis guidelines currently recommend stress ulcer prophylaxis with proton pump inhibitor
(PPI), especially in mechanically ventilated patients for > 48
h. This was endorsed despite the lack of high-level evidence
showing any mortality benefit [29]. The lack of clear benefit with the use of acid suppressants could be hypothesized
largely due to failure in distinguishing between SRMD- and
non-SRMD-related bleeding, such as variceal bleeding, vascular anomalies or diverticular bleeding. Stress ulcer prophylaxis
does not play a preventative role in the non-SMRD-related
bleeding.
GERD, nasogastric tubes (NGTs) and duodenogastroesophageal bile reflux are potential proposed mechanisms of
esophageal injury in critically ill patients [30]. Interestingly,
our study did not show GERD to be a significant predictor of
GIB among ARDS patients (OR: 0.754; P < 0.0001). Wilmer et
al who looked at ventilated patients also noted this interesting
finding, and recognized that majority of esophageal mucosal
injury (75%) were secondary to bile reflux and direct NGT
trauma [31].
Our study showed a substantially increased length of hospital stay and cost of care among patients with ARDS complicated by a GIB.
One of our major findings included a significant increase
in hospital mortality from 11% to 27% among ARDS patients
with GIB as compared to the ARDS group without GIB. The
cause for this is likely to be multifactorial, including severity
of comorbidities, organ failure and age. However, we cannot
comment on the long-term outcomes among this population of
patients after discharge.
The limitation of our study is that data were derived from
an administrative database, which poses the possibility of incorrect classification due to coding errors. However, it is important to note that annual quality assessment of the NIS database is employed by the database administrators to maintain
internal validity. Another limitation of our study is the lack of
long-term data; as such, we can only assess the short-term inpatient outcomes and mortality. Moreover, as a retrospective
observational study, no inferences can be made regarding causality between risk factors and outcomes. The observed risk
factors are reported rather as associations.
Conclusions
In summary, our study is the first large-scale population-based
study in the USA to examine the relationship between GIB
and ARDS in critically ill patients. We concluded that the incidence of GIB among patients with ARDS is relatively high,
reaching up to 2.67%. Furthermore, the occurrence of GIB in
patients with ARDS is associated with an increased mortality rate, longer hospitalizations and a considerable increase in
health care cost. Heightened awareness is needed to consider
early prophylaxis and prevention of this dreaded complication
in susceptible patients with ARDS, specifically those who primarily had pancreatitis, pneumonia or septic shock. The main
limitation of our study is related to our reliance on administrative data prepared for the purpose of billing rather than clinical
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care or research. Further studies, namely, prospective trials, are
needed to shed more light on this subject.
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